Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Pay $587M for Convertible Notes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that its offer to purchase any and all outstanding 2.5 percent convertible senior notes due 2023 has expired, with 95.6 percent of the outstanding notes validly tendered.

The firm also said that it settled its previously announced redemption of all of its outstanding 6.75 percent Senior Subordinated Notes due 2014. It paid an aggregate of approximately $317.0 million to redeem the entire $300,000,000 principal amount of Senior Subordinated Notes outstanding, at a redemption price of 103.375 percent of the principal amount of the notes redeemed.

The firm said that it expects to settle the offers today and pay an aggregate of around $586.6 million to purchase all of the convertible notes that were validly tendered and not withdrawn.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.